References
- Ames B.N., Shigenaga N.K., Hagen T.M. Oxidants, antioxidants and the degenerative diseases. Proceedings of the National Academy of Sciences USA 1993; 90: 7915–7922
- Piotrowski J.J., Hunter G.C., Eskelson C.D., Dubick M.A., Bernhard V.M. Evidence for lipid peroxidation in atherosclerosis. Life Science 1990; 46: 715–721
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809
- Braughler J.M., Hall E.D. Central nervous system, trauma and stroke. II — Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Radical Biology and Medicine 1989; 6: 303–313
- Panetta J.A., Clemens J.A. Novel antioxidant therapy for cerebral ischemia-reperfusion injury. Annals of the New York Academy of Science 1994; 723: 239–245
- Bolli R. Oxygen derived free radical and myocardial reperfusion injury, an overview. Cardiovascular Drugs and Therapy 1991; 5: 249–268
- Rousseau E.J., Davison A.J., Dunn B. Protection by β-carotene and related compounds against oxygen mediated cytotoxicity and genotoxicity, implications for carcinogenesis and anticarcinogenesis. Free Radical Biology and Medicine 1992; 13: 407–433
- Braughler J.M., Hall E.D. Central nervous system, trauma and stroke. I — Biochemical consideration for oxygen radicals formation and lipid peroxidation. Free Radical Biology and Medicine 1989; 6: 289–301
- Hall E.D., Braughler J.M. Role of lipid peroxidation in post-traumatic spinal cord degeneration, a review. Central Nervous System Trauma 1986; 3: 281–293
- Kontos H.A., Wei E.P. Superoxide production in experimental brain injury. Journal of Neurosurgery 1986; 64: 803–807
- Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion-induced injury to gerbial brain. Proceedings of the National Academy of Sciences USA 1990; 87: 5144–5147
- Halliwell B. Free radicals, relative oxygen species and human disease. British Journal of Experimental Pathology 1989; 70: 737–757
- Jacobsen E.J., VanDoornik F.J., Ayer D.E., Belonga R.L., Braughler J.M., Hall E.D., Houser D.J. 2-(Aminomethyl)chroman that inhibit iron-dependent lipid peroxidation and protect against CNS trauma and ischemia. Journal of Medicinal Chemistry 1992; 35: 4464–4472
- Grisar J.M., Bolkenius F.N., Petty M.A., Verue J. 2,3-Dihydro-1-benzofuran-5-ols as analog of α-tocopherol that inhibit in vitro and ex vivo lipid peroxidation and protect mice against CNS trauma. Journal of Medicinal Chemistry 1995; 38: 453–458
- Kato K., Terao S., Shimamoto N., Hirata M. Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acid. Journal Medicinal Chemistry 1988; 31: 793–798
- Nihro Y., Miyataka H., Sudo T. 3-O-alkylascorbic acid as free radical quenchers, synthesis and inhibitory effect on lipid peroxidation. Journal of Medicinal Chemistry 1991; 34: 2152–2157
- Jacobsen F.J., McCall J.M., Ayer D.E., VanDoornik F.J., Palmer J.R., Belonga K.L., Braughler J.M., Hall E.D., Houser D.J., Krook M.A., Runge T.A. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against CNS trauma. Journal of Medicinal Chemistry 1990; 33: 1145–1151
- Oshiro Y., Sarukai Y., Tanaka T., Kikuchi T., Hirose T., Tottori K. Novel cerebroprotective agents with CNS stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivatives. Journal of Medicinal Chemistry 1991; 34: 2014–2023
- Yamamoto M., Sakamoto N., Iwai A. Protective action of YM-737. A new glutathione analog against cerebral ischemia in rats. Research Communications in Chemical Pathology and Pharmacology 1993; 81: 221–232
- Kuehm-Caubere C., Caubere B., Caignard D., Bizot-Espiard J., Pfeiffer B., Cainard D., Guardiola-Lemaitre B., Renard P. Novel indole-2-carboxa-mide and cycloalkeno[1,2-b]indole derivatives. SAR for high inhibition of human LDL peroxidation. Journal of Medicinal Chemistry 1997; 40: 1201–1210
- Ohkawa S., Fukatsu K., Miki S., Hashimoto T., Sakamoto J., Doi T., Nagai Y., Aono T. 5-Aminocoumarans, dual inhibitors of lipid peroxidation and dopamine release with protective effects against CNS trauma and ischemia. Journal of Medicinal Chemistry 1997; 40: 559–573
- Cadet J.L., Sheng P., Ali S., Rothmann R., Epstein E. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. Journal of Neurological Chemistry 1994; 62: 380–383
- Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., Gibb J.W. Role of dopamine in the neurotoxic effect of methamphetamine. Journal of Pharmacological and Experimental Therapy 1985; 233: 539–544
- Clemems J.A., Phebus L.A. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Science 1988; 42: 707–713
- Gross H., Bilk L. Zur reaktion von N-hydroxy succinimid mit dicyclohexyl carbodiimid. Tetrahedron 1968; 24: 6935–6939
- Vajragupta O., Pananookooln S., Tuntiwachwuttikul T., Foye W.O. Ovicidal activity of 6-substituted-2-and -4-aminoquinolines and their mono and bis (thiourea) derivatives against human hookworm. Journal of Science Society of Thailand 1988; 14: 51–59
- Stock J., Gutteridge J.M.C., Sharp J.R., Dormandy T.L. Assay using brain homogenized for measuring the autooxidation activity of biological fluids. Clinical Science 1974; 47: 215–222
- Gutteridge J.M.C. Use of the thiobarbituric acid reaction in oxygen radical chemistry. Analytical Proceedings 1990; 27: 219–221
- Ohkubo M., Kuno A., Sakai H., Takasuki H. Studies on cerebral protection agents VII. Synthesis of novel 4-arylazole derivatives with anti-anoxia activity. Chemical and Pharmaceutical Bulletin 1995; 43: 947–954
- Fraisse L., Verhae B., Roache B. Long-chain substituted uric acid and 5,6-diamino-uracil derivatives as novel agents against free radical process, synthesis and in vivo activity. Journal of Medicinal Chemistry 1993; 36: 1465–1473